Obesity and its metabolic complications: The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease, Int. J. Mol. Sci, vol.15, pp.6184-6223, 2014. ,
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes, Hepatology, vol.64, pp.73-84, 2016. ,
Dietary habits and behaviors associated with nonalcoholic fatty liver disease, World J. Gastroenterol, vol.20, 1756. ,
Nonalcoholic fatty liver disease: Pathogenesis and disease spectrum, Ann. Rev. Pathol, vol.11, pp.451-496, 2016. ,
Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis, N. Engl. J. Med, vol.377, pp.2063-2072, 2017. ,
DOI : 10.1056/nejmra1503519
Non-alcoholic steatohepatitis pathogenesis: Sublethal hepatocyte injury as a driver of liver inflammation, Gut, vol.67, pp.963-972, 2018. ,
Non-alcoholic fatty liver disease (NAFLD)-Pathogenesis, classification, and effect on drug metabolizing enzymes and transporters, Drug Metab. Rev, vol.49, pp.197-211, 2017. ,
DOI : 10.1080/03602532.2017.1293683
URL : http://europepmc.org/articles/pmc5576152?pdf=render
Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease, World J. Gastroenterol, vol.18, pp.3945-3954, 2012. ,
Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis, Pharmacol. Rev, vol.60, pp.311-357, 2008. ,
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD), Metab. Clin. Exp, vol.65, pp.1038-1048, 2016. ,
Drug-Induced Steatohepatitis, Clin. Liver Dis, vol.17, pp.533-546, 2013. ,
Nonalcoholic fatty liver disease, diabetes, obesity, and hepatocellular carcinoma, Clin. Liver Dis, vol.19, pp.361-379, 2015. ,
Binge alcohol consumption aggravates oxidative stress and promotes pathogenesis of NASH from obesity-induced simple steatosis, Mol. Med, vol.20, pp.490-502, 2014. ,
Nonalcoholic fatty liver disease, Curr. Gastroenterol. Rep, vol.1, pp.57-62, 1999. ,
The natural history of nonalcoholic fatty liver: A follow-up study, Hepatology, vol.22, pp.1714-1719, 1995. ,
Metabolism disrupting chemicals and metabolic disorders, Reprod. Toxicol, vol.68, pp.3-33, 2017. ,
Toxicant-associated steatohepatitis, Toxicol. Pathol, vol.41, pp.343-360, 2013. ,
, Biomolecules, vol.8, p.26, 2018.
Alcoholic, nonalcoholic, and toxicant-associated steatohepatitis: Mechanistic similarities and differences, Cell. Mol ,
, Gastroenterol. Hepatol, vol.1, pp.356-367, 2015.
Endocrine-disrupting chemicals and fatty liver disease, Nat. Rev. Endocrinol, vol.13, pp.445-457, 2017. ,
Interaction between alcohol consumption and metabolic syndrome in predicting severe liver disease in the general population, Hepatology, 2017. ,
Effect of multiple binge alcohol on diet-induced liver injury in a mouse model of obesity, Nutr. Diabetes, vol.5, 2015. ,
Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice, Food Chem. Toxicol, vol.113, pp.73-82, 2018. ,
Alcohol increases tumor necrosis factor alpha and decreases nuclear factor-kappab to activate hepatic apoptosis in genetically obese mice, Hepatology, vol.42, pp.1280-1290, 2005. ,
Chronic exposure to low doses of dioxin promotes liver fibrosis development in the c57bl/6j diet-induced obesity mouse model, vol.125, pp.428-436, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02196317
Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity, J. Clin. Transl. Res, vol.3, pp.212-232, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01580159
Inorganic arsenic causes fatty liver and interacts with ethanol to cause alcoholic liver disease in zebrafish, Dis. Models Mech, vol.11, 2018. ,
,
Effects of benzo[a]pyrene exposure on human hepatocellular carcinoma cell angiogenesis, metastasis, and NF-?B signaling, Environ. Health Perspect, vol.123, pp.246-254, 2015. ,
Carcinogenic activity of benzo[a]pyrene in a 2 year oral study in Wistar rats, Food Chem. Toxicol, vol.50, pp.927-935, 2012. ,
Environmental carcinogenesis and pH homeostasis: Not only a matter of dysregulated metabolism, Semin. Cancer Biol, vol.43, pp.49-65, 2017. ,
Role for membrane remodeling in cell death: Implication for health and disease, Toxicology, vol.304, pp.141-157, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00818916
Importance of plasma membrane dynamics in chemical-induced carcinogenesis, Recent Pat. Anticancer Drug Discov, vol.6, pp.347-353, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00696148
Zebrafish larva as a reliable model for in vivo assessment of membrane remodeling involvement in the hepatotoxicity of chemical agents: Zebrafish larva for assessing membrane remodeling by hepatotoxicants, J. Appl. Toxicol, vol.37, pp.732-746, 2017. ,
Role of lipid rafts in liver health and disease, World J. Gastroenterol, vol.17, pp.2520-2535, 2011. ,
Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice, Alcohol. Clin. Exp. Res, vol.35, pp.1509-1518, 2011. ,
Membrane remodeling, an early event in benzo[a]pyrene-induced apoptosis, Toxicol. Appl. Pharmacol, vol.243, pp.68-76, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00729575
NHE-1 relocation outside cholesterol-rich membrane microdomains is associated with its benzo[a]pyrene-related apoptotic function, Cell. Physiol. Biochem, vol.29, pp.657-666, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00871487
, Ethanol induces oxidative stress in primary rat hepatocytes through the early involvement of lipid raft clustering, vol.47, pp.59-70, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00696177
TLR2 and TLR9 contribute to alcohol-mediated liver injury through induction of CXCL1 and neutrophil infiltration, Am. J. Physiol. Gastrointest. Liver Physiol, vol.309, pp.30-41, 2015. ,
Cooperative interaction of benzo[a]pyrene and ethanol on plasma membrane remodeling is responsible for enhanced oxidative stress and cell death in primary rat hepatocytes. Free Radic, Biol. Med, vol.72, pp.11-22, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01018147
NADPH Oxidase-derived peroxynitrite drives inflammation in mice and human nonalcoholic steatohepatitis via tlr4-lipid raft recruitment, Am. J. Pathol, vol.185, pp.1944-1957, 2015. ,
The zebrafish reference genome sequence and its relationship to the human genome, Nature, vol.496, pp.498-503, 2013. ,
New school in liver development: Lessons from zebrafish, Hepatology, vol.50, pp.1656-1663, 2009. ,
Studying non-alcoholic fatty liver disease with zebrafish: A confluence of optics, genetics, and physiology, Cell. Mol. Life Sci, vol.69, pp.3953-3961, 2012. ,
Conserved gene regulation during acute inflammation between zebrafish and mammals, Sci. Rep, vol.7, p.41905, 2017. ,
Zebrafish: An Important Tool for Liver Disease Research, Gastroenterology, vol.149, pp.1361-1377, 2015. ,
Hepatic steatosis in response to acute alcohol exposure in zebrafish requires sterol regulatory element binding protein activation, Hepatology, vol.49, pp.443-452, 2009. ,
Accumulation and metabolism of drugs and CYP probe substrates in zebrafish larvae, Xenobiotica, vol.40, pp.547-557, 2010. ,
Hepatic and vascular mRNA expression in adult zebrafish (Danio rerio) following exposure to benzo-a-pyrene and 2,3,7,8-tetrachlorodibenzo-p-dioxin, Aquat. Toxicol, vol.95, pp.299-306, 2009. ,
Phenotypic and biomarker evaluation of zebrafish larvae as an alternative model to predict mammalian hepatotoxicity, J. Appl. Toxicol, 2016. ,
Exploring the zebrafish embryo as an alternative model for the evaluation of liver toxicity by histopathology and expression profiling, Arch. Toxicol, vol.87, pp.807-823, 2013. ,
Gene expression markers in the zebrafish embryo reflect a hepatotoxic response in animal models and humans, Toxicol. Lett, vol.230, pp.48-56, 2014. ,
A transcriptomics-based hepatotoxicity comparison between the zebrafish embryo and established human and rodent in vitro and in vivo models using cyclosporine A, amiodarone and acetaminophen, Toxicol. Lett, vol.232, pp.403-412, 2015. ,
, Biomolecules, 2018.
Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease, Dis. Models Mech, vol.6, pp.1213-1226, 2013. ,
High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: A novel model for screening anti-hepatic steatosis drugs, Nutr. Metab, vol.12, 2015. ,
Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish, Oncotarget, vol.8, pp.77096-77109, 2017. ,
Lxr-driven enterocyte lipid droplet formation delays transport of ingested lipids, J. Lipid Res, vol.55, pp.1944-1958, 2014. ,
Thioacetamide induced liver damage in zebrafish embryo as a disease model for steatohepatitis, J. Biomed. Sci, vol.13, pp.225-232, 2006. ,
A genetic screen for zebrafish mutants with hepatic steatosis identifies a locus required for larval growth, J. Anat, vol.230, pp.407-413, 2017. ,
, IARD (International Alliance for Responsible Drinking), 2018.
Pilot Metabolome-Wide Association Study of Benzo(a)pyrene in Serum From Military Personnel, J. Occup. Environ. Med, vol.58, p.445, 2016. ,
Pathogenesis of Nonalcoholic Steatohepatitis: Interactions between Liver Parenchymal and Nonparenchymal Cells, BioMed Res. Int, pp.1-11, 2016. ,
Future therapy for non-alcoholic fatty liver disease, Liver Int, vol.38, pp.56-63, 2018. ,
Current and future pharmacological therapies for NAFLD/NASH, J. Gastroenterol, vol.53, pp.362-376, 2018. ,
Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters, Biopharm. Drug Dispos, vol.30, pp.345-355, 2009. ,
The Dual Role of Nrf2 in Nonalcoholic Fatty Liver Disease: Regulation of Antioxidant Defenses and Hepatic Lipid Metabolism, Biomed. Res. Int, vol.597134, 2015. ,
Quantitative imaging of membrane lipid order in cells and organisms, Nat. Protoc, vol.7, pp.24-35, 2012. ,
Measuring Lipid Packing of Model and Cellular Membranes with Environment Sensitive Probes, Langmuir, vol.30, pp.8160-8166, 2014. ,
Spectral imaging toolbox: Segmentation, hyperstack reconstruction, and batch processing of spectral images for the determination of cell and model membrane lipid order. BMC Bioinform, vol.18, 2017. ,
Attenuation by statins of membrane raft-redox signaling in coronary arterial endothelium, J. Pharmacol. Exp. Ther, vol.345, pp.170-179, 2013. ,
,
Pathogenesis of alcoholic liver disease: Pathogenesis of alcoholic liver disease, Hepatol. Res, vol.47, pp.70-79, 2017. ,
New insights into BaP-induced toxicity: Role of major metabolites in transcriptomics and contribution to hepatocarcinogenesis, Arch. Toxicol, vol.90, pp.1449-1458, 2016. ,
, Biomolecules, 2018.
The environmental carcinogen benzo[a]pyrene induces a Warburg-like metabolic reprogramming dependent on NHE1 and associated with cell survival, Sci. Rep, vol.6, 2016. ,
Toll-like receptor-4 signalling in the progression of non-alcoholic fatty liver disease induced by high-fat and high-fructose diet in mice, Clin. Exp. Pharmacol. Physiol, vol.41, pp.482-488, 2014. ,
Dietary Saturated Fat Promotes Development of Hepatic Inflammation Through Toll-Like Receptor 4 in Mice, J. Cell. Biochem, vol.117, pp.1613-1621, 2016. ,
Lipid bilayer stress in obesity-linked inflammatory and metabolic disorders, Biochem. Pharmacol, 2018. ,
Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis, J. Gastroenterol. Hepatol, vol.28, pp.38-42, 2013. ,
Establishment of hepatic cell polarity in the rat hepatoma-human fibroblast hybrid WIF-B9. A biphasic phenomenon going from a simple epithelial polarized phenotype to an hepatic polarized one, J. Cell Sci, vol.109, pp.1623-1635, 1996. ,
Cytochrome P450 expression-induction profile and chemically mediated alterations of the WIF-B9 cell line, Biol. Cell, vol.98, pp.23-32, 2006. ,
Ethanol-induced apoptosis in polarized hepatic cells possibly through regulation of the Fas pathway, Alcohol. Clin. Exp. Res, vol.30, 1906. ,
Aryl hydrocarbon receptor ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances liver damage in bile duct-ligated mice, Toxicology, vol.280, pp.10-17, 2011. ,
Alcoholic fatty liver: Its pathogenesis and mechanism of progression to inflammation and fibrosis, Alcohol, vol.34, pp.9-19, 2004. ,
NRF2 Protection against Liver Injury Produced by Various Hepatotoxicants, Oxid. Med. Cell. Longev, pp.1-8, 2013. ,
Effect of Graded Nrf2 Activation on Phase-I and-II Drug Metabolizing Enzymes and Transporters in Mouse Liver, PLoS ONE, vol.7, 2012. ,
NRF2 as an Emerging Therapeutic Target, Oxid. Med. Cell. Longev, pp.1-2, 2017. ,
Is immunity a mechanism contributing to statin-induced diabetes? Adipocyte, vol.4, pp.232-238, 2015. ,
Inflammatory Stress Sensitizes the Liver to Atorvastatin-Induced Injury in ApoE-/-Mice, PLoS ONE, vol.11, 2016. ,
The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease. Dig. Liver Dis, vol.47, pp.4-11, 2015. ,
Statins Increase Mitochondrial and Peroxisomal Fatty Acid Oxidation in the Liver and Prevent Non-Alcoholic Steatohepatitis in Mice, Diabetes Metab. J, vol.40, 2016. ,
SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy ,
Simvastatin Ameliorates Liver Fibrosis via Mediating Nitric Oxide Synthase in Rats with Non-Alcoholic Steatohepatitis-Related Liver Fibrosis, PLoS ONE, vol.8, 2013. ,
Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-?-lowering property. Dig. Liver Dis, vol.44, pp.492-496, 2012. ,
, Biomolecules, vol.8, 2018.
Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin, Arab J. Gastroenterol, vol.12, pp.80-85, 2011. ,
Lipid-lowering agents inhibit hepatic steatosis in a non-alcoholic steatohepatitis-derived hepatocellular carcinoma mouse model, Eur. J. Pharmacol, vol.772, pp.22-32, 2016. ,
Nonalcoholic fatty liver disease and statins, Metab. Clin. Exp, vol.64, pp.1215-1223, 2015. ,
Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats, Liver Int, vol.33, pp.301-311, 2013. ,
Cholesterol-lowering therapy for the treatment of nonalcoholic fatty liver disease: An update, Curr. Opin. Lipidol, vol.22, pp.489-496, 2011. ,
Comparison of Dietary Control and Atorvastatin on High Fat Diet Induced Hepatic Steatosis and Hyperlipidemia in Rats, Lipids Health Dis, vol.10, 2011. ,
High-fat Feeding Paradigm for Larval Zebrafish: Feeding, Live Imaging, and Quantification of Food Intake, J. Vis. Exp, vol.116, 2016. ,
Developmental expression and nutritional regulation of a zebrafish gene homologous to mammalian microsomal triglyceride transfer protein large subunit: Regulation of mtp Expression in Zebrafish, Dev. Dyn, vol.232, pp.506-518, 2005. ,
Zebrafish obesogenic test: A tool for screening molecules that target adiposity, J. Lipid Res, vol.52, pp.1765-1772, 2011. ,
An open-source platform for biological-image analysis, Nat. Methods, vol.9, pp.676-682, 2012. ,
Liver histopathology of the fish Brachydanio rerio hamilton-buchman after acute exposure to sublethal levels of the organophosphate dimethoate 500, Rev. Bras. Zool, vol.15, pp.441-450, 1998. ,
Hepatocellular ballooning in NASH, J. Hepatol, vol.53, pp.719-723, 2010. ,
DOI : 10.1016/j.jhep.2010.04.031
URL : http://europepmc.org/articles/pmc2930100?pdf=render